FDA’s Science- and Risk-Based Framework and Genome Editing in Animals, Heather Lombardi, U.S. Food and Drug Administration
This talk was presented during the National Academy of Sciences Colloquium: Life 2.0: The Promise and Challenge of a CRISPR Path to a Sustainable Planet in Irvine, CA December 10-11, 2019.
Organized by Barbara Meyer, Fyodor Urnov and Dana Carroll
Illustration by Maya Peters Kostman, Innovative Genomics Institute.